| Literature DB >> 33639249 |
Antoine Andremont1, Julie Cervesi2, Pierre-Alain Bandinelli2, Fabien Vitry2, Jean de Gunzburg2.
Abstract
Homeostasis of the intestinal microbiota is currently recognized as a major contributor to human health. Furthermore, intestinal dysbiosis is associated with a multitude of consequences, including intestinal colonization by antibiotic-resistant or pathogenic bacteria, such as Clostridioides difficile, and reduced efficacy of promising anticancer immunotherapies. By far, the most immediate and drastic exposure leading to dysbiosis is antibiotic treatment. Many attempts have been made to prevent or repair antibiotic-associated dysbiosis. Here, we review these innovations and the difficulties associated with their development.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33639249 DOI: 10.1016/j.drudis.2021.02.022
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851